Eledon Pharmaceuticals Inc. Common Stock (ELDN)
About The Company
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company’s lead compound in development is AT-1501 which is the next generation anti-CD40L antibody.
| IPO Year | Sector | Industry |
|---|---|---|
| 2014 | Health Care | Biotechnology: Pharmaceutical Preparations |
Eledon Pharmaceuticals Inc. (ELDN) Latest News
Company Contact & Address (ELDN)
| Corporate Headquarters | Phone | Website |
|---|---|---|
| 19900 MACARTHUR BOULEVARD SUITE 550, IRVINE, California, 92612, United States |
+1 949 238-8090 | Official ELDN Website |
ELDN Key Executives
Ownership and management information.
Key Data Points*
| Exchange | Not Available | Market Cap | Not Available |
|---|---|---|---|
| Sector | Health Care | P/E Ratio | Not Available |
| Industry | Biotechnology: Pharmaceutical Preparations | Forward P/E 1 Yr. | Not Available |
| 1 Year Target | Not Available | Earnings Per Share (EPS) | Not Available |
| Today’s High/Low | Not Available | Annualized Dividend | Not Available |
| Share Volume | Not Available | Ex Dividend Date | Not Available |
| Average Volume | Not Available | Dividend Pay Date | Not Available |
| Previous Close | Not Available | Current Yield | Not Available |
| 52 Week High/Low | Not Available | Beta | Not Available |
* Information and data may delayed
Officers & Directors @ ELDN
Jobs & Employment at Eledon Pharmaceuticals Inc.
| LinkedIn Company Page | https://www.linkedin.com/company/eledon-pharma |
|---|---|
| Official Career & Employment Page | Employment & Jobs at Eledon Pharmaceuticals Inc. (ELDN) |
Related & Similar Stock Symbols
 WBEVWinc Inc. Common Stock
|
 GSMGWGlory Star New Media Group Holdings Limited …
|
 SFIXStitch Fix Inc. Class A Common Stock
|
Thursday, August 11, 2022, 11:15 am (EST)
